Search clinical trials for: Arvekap 0.1mg (Triptorelin, Ipsen, France)

Total 16 results

Eugonia

Completed

Flexible GnRH Antagonist vs Flare up GnRH Agonist Protocol in Poor Responders

Infertility | Premature Ovarian Failure

Greece
Eugonia

Unknown

Comparison Between GnRH Agonist and GnRH Antagonist Protocols of Ovarian Stimulation in PCOS Patients

Polycystic Ovary Syndrome | Ovarian Hyperstimulation Syndrome

Greece
Eugonia

Unknown

Comparison of the Long GnRH Agonist Protocol and the Flexible GnRH Antagonist Protocol of Ovarian Stimulation

Infertility

Greece
Masaryk University
Ministry of Health, Czech Republic

Completed

Prevention of Ovarian Function Damage by a GnRH Analogue During Chemotherapy in Hodgkin Lymphoma Patients (OVARONKO)

Hodgkin Disease | Hodgkin Lymphoma

Czech Republic
Centre Hospitalier Universitaire Ibn Rochd

Completed

GnRH Agonist Trigger and Modified Luteal Phase Support, Adding a Bolus of GnRHa at the Time of Implantation - a RCT (GTMLPSGI)

Infertility

Algeria
Antalya IVF

Withdrawn

The Effect of a Dual Trigger on Intracytoplasmic Sperm Injection (ICSI) Reproductive Outcomes

Pregnancy | Ovarian Hyperstimulation Syndrome

Turkey
Centro Ginecologia y Obstetricia.
University of Valencia

Completed

Administration of GnRH Antagonist to Oocyte Donation Recipients (GnRH-Ovodon)

Pregnancy | Embryo Implantation

Spain
Armando Santoro, MD

Terminated

Anti-Mullerian Hormone (AMH) as Marker of Ovarian Reserve

Breast Cancer

Italy
IVI Madrid

Completed

Dual Triggering in Patients With a High Immature Oocyte Rate

INFERTILITY
National University of Malaysia

Completed

Luteal Phase Support In IVF Women Using GnRH Agonist

Luteal Phase Defect | IVF

Malaysia
American University of Beirut Medical Center

Completed

Dual Trigger in the Final Oocyte Maturation in Poor Ovarian Responders

Poor Ovarian Reserve

Lebanon
Cairo University

Unknown

Accuracy of Ultrasound Markers Versus Biochemical Markers in Prediction of Ovarian Response in Obese Women Undergoing IVF/ICSI Treatment

Invitro Fertilization

Egypt
Tel-Aviv Sourasky Medical Center

Unknown

Combination of Gonadotropin-releasing Hormone Agonist and Human Chorionic Gonadotropin Triggered by Normal Responder in GnRH-antagonist Cycles

In-vitro Fertilization
Instituto Valenciano de Infertilidad, IVI VALENCIA

Unknown

Comparison Between Natural and Artificial Cycle in Recipient Oocyte Patients

Infertility

Spain
Helsinn Healthcare SA

Active, not recruiting

Oral Akynzeo® vs Standard of Care in Preventing CINV in High-risk MEC Patients (MyRisk) (CINV)

Chemotherapy-induced Nausea and Vomiting

Spain, Germany, Switzerland, China, Czechia, United Kingdom, Greece
NRG Oncology
National Cancer Institute (NCI)

Recruiting

Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score

Prostate Adenocarcinoma

United States, Canada

3

Subscribe